Metabolic Responses to Early and High Protein Supplementation in a Randomized Trial Evaluating the Prevention of Hyperkalemia in Extremely Low Birth Weight Infants

Cynthia Blanco, Alison Falck, Belinda Kay Green, John E. Cornell, Alice K Gong

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: To determine whether early and higher intravenous amino acid (EHAA) supplementation decreases hyperkalemia in extremely low birth weight (ELBW) infants (<1000 g). Study design: Infants were enrolled at birth in a randomized, double-masked, prospective fashion and treated for 7 days. The standard group (SAA) infants received intravenous amino acid (AA) starting at 0.5 g · kg-1 · d-1 and increased by 0.5 g · kg-1 every day to a maximum of 3 g · kg-1 · d-1. EHAA group infants received 2 g · kg-1 · d-1 of AA soon after birth and advanced by 1 g · kg-1 every day to 4 g · kg-1 · d-1. Data analysis was by SPSS 11.5, with statistical significance at α = 0.05 and 90% power to determine a difference in mean K+ level of 2. Results: Sixty-two patients, mean gestational age of 26.0 ± 2.0 weeks and birth weight of 775 ± 136 g, were enrolled. Hyperkalemia (K+ ≥6.5 mEq/L) occurred in 13% of the studied population; no difference in incidence of hyperkalemia was found between the SAA and EHAA groups (16% vs 10%, respectively, P = .70). Serum blood urea nitrogen was higher in the EHAA group. AA infusion was stopped early in 6 patients for high blood urea nitrogen or elevated ammonia level. Conclusions: During the study period, hyperkalemia decreased significantly and was not affected by EHAA supplementation in the first week of life.

Original languageEnglish (US)
Pages (from-to)535-540
Number of pages6
JournalJournal of Pediatrics
Volume153
Issue number4
DOIs
StatePublished - Oct 2008

Fingerprint

Extremely Low Birth Weight Infant
Hyperkalemia
Amino Acids
Proteins
Blood Urea Nitrogen
Parturition
Ammonia
Birth Weight
Gestational Age

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Metabolic Responses to Early and High Protein Supplementation in a Randomized Trial Evaluating the Prevention of Hyperkalemia in Extremely Low Birth Weight Infants. / Blanco, Cynthia; Falck, Alison; Green, Belinda Kay; Cornell, John E.; Gong, Alice K.

In: Journal of Pediatrics, Vol. 153, No. 4, 10.2008, p. 535-540.

Research output: Contribution to journalArticle

@article{dc0a2a8680d146f99079bf9ff48c005f,
title = "Metabolic Responses to Early and High Protein Supplementation in a Randomized Trial Evaluating the Prevention of Hyperkalemia in Extremely Low Birth Weight Infants",
abstract = "Objective: To determine whether early and higher intravenous amino acid (EHAA) supplementation decreases hyperkalemia in extremely low birth weight (ELBW) infants (<1000 g). Study design: Infants were enrolled at birth in a randomized, double-masked, prospective fashion and treated for 7 days. The standard group (SAA) infants received intravenous amino acid (AA) starting at 0.5 g · kg-1 · d-1 and increased by 0.5 g · kg-1 every day to a maximum of 3 g · kg-1 · d-1. EHAA group infants received 2 g · kg-1 · d-1 of AA soon after birth and advanced by 1 g · kg-1 every day to 4 g · kg-1 · d-1. Data analysis was by SPSS 11.5, with statistical significance at α = 0.05 and 90{\%} power to determine a difference in mean K+ level of 2. Results: Sixty-two patients, mean gestational age of 26.0 ± 2.0 weeks and birth weight of 775 ± 136 g, were enrolled. Hyperkalemia (K+ ≥6.5 mEq/L) occurred in 13{\%} of the studied population; no difference in incidence of hyperkalemia was found between the SAA and EHAA groups (16{\%} vs 10{\%}, respectively, P = .70). Serum blood urea nitrogen was higher in the EHAA group. AA infusion was stopped early in 6 patients for high blood urea nitrogen or elevated ammonia level. Conclusions: During the study period, hyperkalemia decreased significantly and was not affected by EHAA supplementation in the first week of life.",
author = "Cynthia Blanco and Alison Falck and Green, {Belinda Kay} and Cornell, {John E.} and Gong, {Alice K}",
year = "2008",
month = "10",
doi = "10.1016/j.jpeds.2008.04.059",
language = "English (US)",
volume = "153",
pages = "535--540",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Metabolic Responses to Early and High Protein Supplementation in a Randomized Trial Evaluating the Prevention of Hyperkalemia in Extremely Low Birth Weight Infants

AU - Blanco, Cynthia

AU - Falck, Alison

AU - Green, Belinda Kay

AU - Cornell, John E.

AU - Gong, Alice K

PY - 2008/10

Y1 - 2008/10

N2 - Objective: To determine whether early and higher intravenous amino acid (EHAA) supplementation decreases hyperkalemia in extremely low birth weight (ELBW) infants (<1000 g). Study design: Infants were enrolled at birth in a randomized, double-masked, prospective fashion and treated for 7 days. The standard group (SAA) infants received intravenous amino acid (AA) starting at 0.5 g · kg-1 · d-1 and increased by 0.5 g · kg-1 every day to a maximum of 3 g · kg-1 · d-1. EHAA group infants received 2 g · kg-1 · d-1 of AA soon after birth and advanced by 1 g · kg-1 every day to 4 g · kg-1 · d-1. Data analysis was by SPSS 11.5, with statistical significance at α = 0.05 and 90% power to determine a difference in mean K+ level of 2. Results: Sixty-two patients, mean gestational age of 26.0 ± 2.0 weeks and birth weight of 775 ± 136 g, were enrolled. Hyperkalemia (K+ ≥6.5 mEq/L) occurred in 13% of the studied population; no difference in incidence of hyperkalemia was found between the SAA and EHAA groups (16% vs 10%, respectively, P = .70). Serum blood urea nitrogen was higher in the EHAA group. AA infusion was stopped early in 6 patients for high blood urea nitrogen or elevated ammonia level. Conclusions: During the study period, hyperkalemia decreased significantly and was not affected by EHAA supplementation in the first week of life.

AB - Objective: To determine whether early and higher intravenous amino acid (EHAA) supplementation decreases hyperkalemia in extremely low birth weight (ELBW) infants (<1000 g). Study design: Infants were enrolled at birth in a randomized, double-masked, prospective fashion and treated for 7 days. The standard group (SAA) infants received intravenous amino acid (AA) starting at 0.5 g · kg-1 · d-1 and increased by 0.5 g · kg-1 every day to a maximum of 3 g · kg-1 · d-1. EHAA group infants received 2 g · kg-1 · d-1 of AA soon after birth and advanced by 1 g · kg-1 every day to 4 g · kg-1 · d-1. Data analysis was by SPSS 11.5, with statistical significance at α = 0.05 and 90% power to determine a difference in mean K+ level of 2. Results: Sixty-two patients, mean gestational age of 26.0 ± 2.0 weeks and birth weight of 775 ± 136 g, were enrolled. Hyperkalemia (K+ ≥6.5 mEq/L) occurred in 13% of the studied population; no difference in incidence of hyperkalemia was found between the SAA and EHAA groups (16% vs 10%, respectively, P = .70). Serum blood urea nitrogen was higher in the EHAA group. AA infusion was stopped early in 6 patients for high blood urea nitrogen or elevated ammonia level. Conclusions: During the study period, hyperkalemia decreased significantly and was not affected by EHAA supplementation in the first week of life.

UR - http://www.scopus.com/inward/record.url?scp=51449098831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51449098831&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2008.04.059

DO - 10.1016/j.jpeds.2008.04.059

M3 - Article

C2 - 18589451

AN - SCOPUS:51449098831

VL - 153

SP - 535

EP - 540

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 4

ER -